Results 51 to 60 of about 33,313 (208)
Siriraj Medical Journal, 2018 Objective: To compare length of hospital stay (LOS) and surgical rate in patients hospitalized with pelvic inflammatory disease (PID) who received either cefoxitin plus doxycycline regimen or clindamycin plus gentamicin regimen.
Pattraporn Chera-aree +3 more
doaj +3 more sources
Brazilian Journal of Microbiology, 2013 Clinical isolates of carbapenem-resistant Klebsiella pneumoniae (K. pneumoniae) strains are being increased worldwide. Five pan-resistant K. pneumoniae strains have been isolated from respiratory and ICU wards in a Chinese hospital, and reveal strong ...
Weifeng Shi +6 more
semanticscholar +1 more source
Clinical Case Reports, Volume 14, Issue 2, February 2026.ABSTRACT In patients in peritoneal dialysis (PD) who develop exit site and/or catheter tunnel infections, expeditious identification of the causative organism and early implementation of treatment are important to ensure good outcomes. Among the many causative organisms, the diagnosis of Mycobacterium fortuitum is particularly challenging, with its ...
Rina Takahashi +4 more
wiley +1 more source
Future Journal of Pharmaceutical Sciences, 2018 This work, introduces different powerful chemometric methods for determination of cefoxitin-sodium in presence of its alkali-induced degradation product without prior separation steps, dubbed; Principal component regression, Partial least squares with ...
Khalid Abdel-Salam M. Attia +3 more
doaj +1 more source
CRISPR‐based genome editing reveals the roles of efflux pumps in Mycobacterium abscessus
mLife, Volume 5, Issue 1, Page 68-82, February 2026.Abstract Mycobacterium abscessus, one of the most antimicrobial‐resistant bacteria, is increasingly recognized as the cause of infections that are difficult to treat. Novel genetic manipulation tools are required to elucidate the biology, pathogenesis, and antibiotic resistance mechanisms of M. abscessus.
Sishang Li +7 more
wiley +1 more source
Clinical and Translational Science, Volume 19, Issue 2, February 2026.ABSTRACT Nontuberculous mycobacteria (NTM) are emerging global pathogens. This study aimed to analyze the clinical features, species distribution, and drug resistance profiles of NTM infections in a northern Chinese hospital. A retrospective cohort study included 1769 patients with suspected mycobacterial infection from August 2023 to July 2025.
Kedi Wang +4 more
wiley +1 more source
Emerging Infectious Diseases, 2003 AmpC β-lactamase, altered porins, or both are usually responsible for cefoxitin resistance in Escherichia coli. We examined the relative importance of each. We studied 18 strains of clinical isolates with reduced cefoxitin susceptibility and 10 initially-
Brian Clarke +3 more
doaj +1 more source
EFSA Journal, Volume 24, Issue 2, February 2026.Abstract This report presents the main findings of the 2023–2024 harmonised antimicrobial resistance (AMR) monitoring in Salmonella spp., Campylobacter jejuni and Campylobacter coli from humans, food‐producing animals (broilers, laying hens, fattening turkeys, fattening pigs and bovines under 1 year of age), and derived meat.
European Food Safety Authority (EFSA) +1 more
wiley +1 more source
Advanced Science, Volume 13, Issue 2, 9 January 2026.Punicalagin, a pomegranate molecule, helps the body fight Mycobacterium abscessus. It preferentially boosts interstitial macrophages in the lung, stabilizing mitochondria and switching on the autophagy via SIRT1/FoxO3a, which lowers bacterial load without directly killing bacteria.
Kefan Bi +4 more
wiley +1 more source
Microbial Biotechnology, Volume 19, Issue 1, January 2026.Betulinic acid reduces infection by Staphylococcus aureus biofilms on implants by inhibiting their formation and adhesion, decreasing EPS and eDNA formation and enhancing immune clearance. Simultaneously, it reduces skin tissue inflammation, enhances type I collagen production, and promotes wound healing.
Dongbin Guo +8 more
wiley +1 more source